Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-κB activation
(2010) Biochemical Pharmacology — Vol. 79, n° 10, p. 1462-1472 (2010)
Files
1-s2.pdf
Restricted Access - Adobe PDF
- 624.8 KB
Details
- Authors
- Abstract
- In this work, we aimed to build a 3D-model of NIK and to study the binding of pyrazolo[4,3-c]isoquinolines with a view to highlight the structural elements responsible for their inhibitory potency. However, in the course of this work, we unexpectedly found that the pyrazolo[4,3-c]isoquinolines initially reported as NIK inhibitors were neither inhibitors of this enzyme nor of the alternative NF-κB pathway, but were in fact inhibitors of another kinase, the TGF-β activated kinase 1 (TAK1) which is involved in the classical NF-κB pathway. © 2010 Elsevier Inc. All rights reserved.
- Affiliations
Citations
Mortier, J., Frédérick, R., Ganeff, C., Remouchamps, C., Talaga, P., Pochet, L., Wouters, J., Piette, J., Dejardin, E., & Masereel, B. (2010). Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-κB activation. Biochemical Pharmacology, 79(10), 1462-1472. https://doi.org/10.1016/j.bcp.2010.01.007 (Original work published 2010)